Since there was no distinctly normal range of FGF-21 for subjects with T2DM, a validated cut-off value of FGF-21 that can predict the renal outcomes accurately may facilitate the clinical applications. The gene discussed is FGF21; the disease is type 2 diabetes mellitus.